Complete Genomics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 88   

Articles published

GNOM 3.14
price chart
Complete Genomics Workshop at ASHG 2014
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Complete Genomics, Inc., a leader in accurate whole human genomic sequencing, will host a luncheon workshop, Clinical Applications of Whole Genome Sequencing, for attendees at the upcoming 64th Annual ...
Related articles »  
Early access program for human chromosome mapping analytical service ...
Hitachi High-Technologies Corporation and OpGen, Inc., a leading genetic analysis company, announced the introduction of an Early Access Program for its upcoming Human Chromosome ExplorerSM, human chromosome mapping analytical service for ... with a ...
Agilent Technologies Introduces miRNA Microarrays Featuring Latest miRBase ...
SANTA CLARA, Calif., Oct 21, 2014 (BUSINESS WIRE) -- Agilent Technologies Inc. A, +3.02% today announced updates to its SurePrint miRNA Microarrays to include targets from the latest public miRNA miRBase database.
Related articles »  
Illumina's (ILMN) CEO Jay Flatley on Q3 2014 Results - Earnings Call ...
Good day, ladies and gentlemen, and welcome to the Q3 2014 Illumina Inc. Earnings Conference Call. My name is Whitley, and I'll be your operator for today.
Illumina, Inc. (NASDAQ:ILMN) Comes Up With New Reagent Kits for HiSeq 2500 ...  USMarketsDaily (blog)
Related articles »  
Agilent Technologies Introduces Focused Exome Kit with Unparalleled ...
BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced the SureSelect Focused Exome, a target enrichment solution that enables deep coverage of only those target regions that have been associated with disease.
Personalis Introduces New Services for Cancer Research and Clinical Trials
Personalis Inc. a leading genomics-based service provider today announced it is launching an expanded portfolio of cancer research solutions based on its ACE (Accuracy and Content Enhanced) sequencing informatics and content technology platform ...
Related articles »  
How do you keep the tech talent on the beach when Silicon Valley's just beyond ...
From left, the board of Santa Cruz Works, a public-private venture working to build the local tech talent pool: Zachary Sanborn, co-founder and CTO of Five3 Genomics; Mark Adams, Santa Cruz Works program manager; Bud Colligan, founder and CEO of South ...
Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG ...
CAMBRIDGE, Mass., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced the initiation of a Phase 1/2 multicenter study of ...
Related articles »  
In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
The SpCas9 nuclease can be reprogrammed to target specific genomic loci in mammalian cells using single guide RNAs (sgRNAs) and has been used in a variety of genome editing applications1. ..... In contrast to classical mouse models, which feature ...
Evaluating The Best Biotech ETF Options
For example, the number one holding, Gilead Sciences, Inc. (NASDAQ:GILD), accounts for 15.15 percent of BBH's assets while it accounts for only 8.13 percent of IBB's assets.